share_log
Moomoo 24/7 ·  Mar 13 13:58
Regulus Therapeutics Shares Are Trading Higher After Wells Fargo Maintained an Equal-Weight Rating on the Stock and Raised Its Price Target From $2 to $3
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment